The FDA says new labels will make it easier to spot harmful ingredients. A UVA nutritionist suggests taking a holistic ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

The FDA has expanded the label of Ozempic, approving the Novo Nordisk product for reducing the risk of worsening kidney disease and kidney failure as well as reducing the risk of death.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

(Menopause) The Ohio State University Wexner Medical Center Comprehensive Transplant Center set a record-breaking kidney "donation chain," with 20 surgeries over a 2-day period. (Columbus Dispatch ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Medscape Medical News, December 20, 2024 Europe Allows Novo to Include Reduction Of Kidney Disease in Ozempic Label The European Medicines Agency (EMA) will allow Novo Nordisk to add risk ...

Kidney has no religious labels, this is what External Affairs Minister Sushma Swaraj, undergoing treatment for renal failure, tweeted while thanking Muslim men who offered her their kidneys.

AstraZeneca's fast-growing SGLT2 inhibitor Forxiga could soon get a further boost from approval in the EU as a treatment for chronic kidney disease (CKD) in adults with and without type-2 diabetes.

Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of ...